Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2021-12-09 17:49:02
Oslo, Norway, December 9, 2021 - Reference is made to the announcement on
November 24, 2021, regarding a share capital increase related to the issuance of
2,255,034 new shares to Regeneron at a price of NOK 79.07 per share in
connection with the multi-target license and collaboration agreement announced
on November 23, 2021. The share capital increase has now been registered with
the Norwegian Register of Business Enterprises, and the company's new share
capital is NOK 2,895,027.44, divided into 289,502,744 shares, each with a par
value of NOK 0.01.